|
HY-10015-10mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-10015-100mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-10015-25mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-10015-5mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-10015-50mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-100277-1mg
|
MedChemexpress LLC
|
Mifobate [CAS 76541-72-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100277-5mg
|
MedChemexpress LLC
|
Mifobate [CAS 76541-72-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100557-10g
|
MedChemexpress LLC
|
Hydroxypropyl Cellulose [CAS 9004-64-2]
|
|
|
|
|
HY-100557-5g
|
MedChemexpress LLC
|
Hydroxypropyl Cellulose [CAS 9004-64-2]
|
|
|
|
|
HY-100815D-10mg
|
MedChemexpress LLC
|
(RS)-AMPA (monohydrate) [CAS 76463-67-7]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-100815D-5mg
|
MedChemexpress LLC
|
(RS)-AMPA (monohydrate) [CAS 76463-67-7]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-100849-1mg
|
MedChemexpress LLC
|
JAK 3i [CAS 1918238-72-8]
|
|
|
|
|
HY-101230-1mg
|
MedChemexpress LLC
|
ICI 174864 [CAS 89352-67-0]
|
|
|
|
|
HY-10131-10mg
|
MedChemexpress LLC
|
Procaspase-3/6 activator 1 [CAS 1100353-03-4]
|
|
|
|
|
HY-10131-100mg
|
MedChemexpress LLC
|
Procaspase-3/6 activator 1 [CAS 1100353-03-4]
|
|
|
|
|
HY-10131-25mg
|
MedChemexpress LLC
|
Procaspase-3/6 activator 1 [CAS 1100353-03-4]
|
|
|
|
|
HY-10131-5mg
|
MedChemexpress LLC
|
Procaspase-3/6 activator 1 [CAS 1100353-03-4]
|
|
|
|
|
HY-10131-50mg
|
MedChemexpress LLC
|
Procaspase-3/6 activator 1 [CAS 1100353-03-4]
|
|
|
|
|
HY-101359-10mg
|
MedChemexpress LLC
|
TPMPA [CAS 182485-36-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101453-1mg
|
MedChemexpress LLC
|
Ceefourin 1 [CAS 315702-40-0]
|
|
Cancer-programmed cell death
|
|
|
HY-101453-10mg
|
MedChemexpress LLC
|
Ceefourin 1 [CAS 315702-40-0]
|
|
Cancer-programmed cell death
|
|
|
HY-101453-100mg
|
MedChemexpress LLC
|
Ceefourin 1 [CAS 315702-40-0]
|
|
Cancer-programmed cell death
|
|
|
HY-101453-25mg
|
MedChemexpress LLC
|
Ceefourin 1 [CAS 315702-40-0]
|
|
Cancer-programmed cell death
|
|
|
HY-101453-5mg
|
MedChemexpress LLC
|
Ceefourin 1 [CAS 315702-40-0]
|
|
Cancer-programmed cell death
|
|
|
HY-101453-50mg
|
MedChemexpress LLC
|
Ceefourin 1 [CAS 315702-40-0]
|
|
Cancer-programmed cell death
|
|
